Design and synthesis of conformationally-constrained MMP inhibitors.Natchus, M.G., Cheng, M., Wahl, C.T., Pikul, S., Almstead, N.G., Bradley, R.S., Taiwo, Y.O., Mieling, G.E., Dunaway, C.M., Snider, C.E., McIver, J.M., Barnett, B.L., McPhail, S.J., Anastasio, M.B., De, B.
(1998) Bioorg Med Chem Lett 8: 2077-2080
- PubMed: 9873489
- DOI: 10.1016/s0960-894x(98)00370-9
- Structures With Same Primary Citation
- PubMed Abstract:
A novel series of conformationally constrained matrix metalloprotease inhibitors was identified. The potencies observed for these inhibitors were highly dependent upon the substitution pattern on the caprolactam ring as well as the succinate moiety.
Procter and Gamble Pharmaceuticals, Health Care Research Center, Mason, OH 45040, USA.